Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 2341 AL 2355

Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease

Guilherme L, Kalil J.

J Clin Immunol. 2010 Jan;30(1):17-23. doi: 10.1007/s10875-009-9332-6. Epub 2009 Oct 3.

Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins

Silva JL, Vieira TC, Gomes MP, Bom AP, Lima LM, Freitas MS, Ishimaru D, Cordeiro Y, Foguel D.

Acc Chem Res. 2010 Feb 16;43(2):271-9. doi: 10.1021/ar900179t.

Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?

Correia SC, Moreira PI.

J Neurochem. 2010 Jan;112(1):1-12. doi: 10.1111/j.1471-4159.2009.06443.x. Epub 2009 Oct 20.

Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease

Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG.

J Neurochem. 2010 Jan;112(1):112-22. doi: 10.1111/j.1471-4159.2009.06442.x. Epub 2009 Oct 20.

Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure

Williams BB, Li D, Wegrzynowicz M, Vadodaria BK, Anderson JG, Kwakye GF, Aschner M, Erikson KM, Bowman AB.

J Neurochem. 2010 Jan;112(1):227-37. doi: 10.1111/j.1471-4159.2009.06445.x. Epub 2009 Oct 21.

Mitochondria: a therapeutic target in neurodegeneration

Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA.

Biochim Biophys Acta. 2010 Jan;1802(1):212-20. doi: 10.1016/j.bbadis.2009.10.007. Epub 2009 Oct 21.

Inflammation in transgenic mouse models of neurodegenerative disorders

Schwab C, Klegeris A, McGeer PL.

Biochim Biophys Acta. 2010 Oct;1802(10):889-902. doi: 10.1016/j.bbadis.2009.10.013. Epub 2009 Oct 31.

Chapter 33: the history of movement disorders

Lanska DJ.

Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.

A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease

van Walsem MR, Sundet K, Retterstøl L, Sundseth Ø.

J Clin Exp Neuropsychol. 2010 Jul;32(6):590-8. doi: 10.1080/13803390903337878. Epub 2009 Nov 12.

Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells

Wang CJ, Hu CP, Xu KP, Yuan Q, Li FS, Zou H, Tan GS, Li YJ.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Jan;381(1):73-81. doi: 10.1007/s00210-009-0470-4. Epub 2009 Nov 20.

Tongue protrusion and feeding dystonia: a hallmark of chorea-acanthocytosis

Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J, Danek A.

Mov Disord. 2010 Jan 15;25(1):127-9. doi: 10.1002/mds.22863.

Chorea-acanthocytosis with upper motor neuron degeneration and 3419_3420 delCA and 3970_3973 delAGTC VPS13A mutations

Miki Y, Nishie M, Ichiba M, Nakamura M, Mori F, Ogawa M, Kaimori M, Sano A, Wakabayashi K.

Acta Neuropathol. 2010 Feb;119(2):271-3. doi: 10.1007/s00401-009-0617-x. Epub 2009 Dec 1.

Critical role of transglutaminase and other stress proteins during neurodegenerative processes

Caccamo D, Currò M, Condello S, Ferlazzo N, Ientile R.

Amino Acids. 2010 Feb;38(2):653-8. doi: 10.1007/s00726-009-0428-3. Epub 2009 Dec 5.

Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice

Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.

Brain. 2010 Jan;133(Pt 1):189-204. doi: 10.1093/brain/awp290. Epub 2009 Dec 7.

Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR

Holl AK, Wilkinson L, Painold A, Holl EM, Bonelli RM.

Int Clin Psychopharmacol. 2010 Jan;25(1):46-50. doi: 10.1097/YIC.0b013e3283348018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias